Sign In
Buy HRMY
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
How Harmony Biosciences Can Prove Its Skeptics Wrong
12:04pm, Wednesday, 28'th Jan 2026
Harmony Biosciences has thrived due to the success of its Wakix narcolepsy treatment. Harmony is looking to extend the life of the intellectual property behind Wakix through new versions of the compou
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed?
12:02pm, Tuesday, 27'th Jan 2026
Harmony's approved narcolepsy drug Wakix has been a huge financial success. Controversy and litigation surrounding Wakix have held back the stock.
HRMY or ARGX: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 26'th Jan 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or argenex SE (ARGX). But which of these two stocks
I Was Shocked to Find This Value-Priced Biotech Growth Stock
12:01pm, Monday, 26'th Jan 2026
The biotechnology area includes many stocks that command premium valuations because of their future prospects. So when a more attractively priced option appears, it's worth closer examination.
Should Value Investors Buy Harmony Biosciences (HRMY) Stock?
10:40am, Monday, 26'th Jan 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Campbell & CO Investment Adviser LLC Has $796,000 Holdings in Harmony Biosciences Holdings, Inc. $HRMY
04:31am, Tuesday, 20'th Jan 2026
Campbell and CO Investment Adviser LLC lessened its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) by 35.7% during the undefined quarter, according to its most recent disclosu
Buy These 5 Price-to-Book Value Stocks for Gains in 2026
09:50am, Thursday, 15'th Jan 2026
Five low price-to-book stocks stand out for 2026, as undervalued valuations and solid growth outlooks put them on investors' radar.
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
09:56pm, Tuesday, 13'th Jan 2026
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Harmony Biosciences (HRMY) is an Incredible Growth Stock: 3 Reasons Why
01:46pm, Tuesday, 13'th Jan 2026
Harmony Biosciences (HRMY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenue for Q4 and full year 2025 of approximately $
HRMY vs. LQDA: Which Stock Is the Better Value Option?
12:40pm, Thursday, 08'th Jan 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and Liquidia Corporation (LQDA). But which of these two st
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
10:40am, Thursday, 08'th Jan 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CX Institutional Has $6.35 Million Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY
05:05am, Thursday, 08'th Jan 2026
CX Institutional lifted its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) by 10.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commis
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
08:05am, Wednesday, 07'th Jan 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced its participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Jeffr
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Recommendation of “Moderate Buy” from Analysts
01:44am, Wednesday, 07'th Jan 2026
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten ratings firms that are currently covering the stock, Marketbe
